Tuesday, 22 Jul 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • ScienceAlert
  • White
  • Watch
  • Trumps
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > Janet Woodcock, top former FDA official, joins board of patient advocacy group
Health and Wellness

Janet Woodcock, top former FDA official, joins board of patient advocacy group

Last updated: October 13, 2024 1:01 am
Share
Janet Woodcock, top former FDA official, joins board of patient advocacy group
SHARE

Every Cure, an organization dedicated to finding existing drugs that could potentially cure hard-to-treat diseases, has gained a valuable new ally in Janet Woodcock. Woodcock, who was a prominent figure at the Food and Drug Administration for many years, recently joined the organization’s board.

The driving force behind Every Cure is physician David Fajgenbaum, who has a personal connection to the mission of the organization. As a young medical student, Fajgenbaum was diagnosed with a rare and life-threatening disease that left him weak and on the brink of death multiple times. After extensive research, he and his doctors discovered that the transplant medicine sirolimus could put his disease into remission, ultimately saving his life.

Initially focused on advocating for patients with Castleman disease, Fajgenbaum’s efforts expanded to include a wide range of rare diseases. Every Cure now aims to identify existing drugs that have the potential to treat these challenging conditions and provide hope for patients in need.

With Woodcock’s expertise and experience in drug regulation and approval, her addition to the board brings valuable insight and guidance to Every Cure. Her knowledge of the pharmaceutical industry and regulatory processes will undoubtedly strengthen the organization’s efforts to identify and repurpose existing drugs for the treatment of rare diseases.

As Every Cure continues its mission to find new treatments and potential cures for hard-to-treat diseases, Woodcock’s involvement promises to enhance the organization’s impact and bring new opportunities for advancing medical research and patient care. It is clear that with dedicated individuals like Fajgenbaum and Woodcock at the helm, Every Cure is poised to make a significant difference in the lives of those affected by rare diseases.

See also  U.K.’s Phased Smoking Ban Moves Closer To Law
TAGGED:advocacyBoardFDAGroupJanetJoinsofficialpatientTopWoodcock
Share This Article
Twitter Email Copy Link Print
Previous Article Tennis player association led by Novak Djokovic calls anti-doping processes ‘broken’ in letter Tennis player association led by Novak Djokovic calls anti-doping processes ‘broken’ in letter
Next Article Smaller pint size unlikely to curb consumption, researchers say Smaller pint size unlikely to curb consumption, researchers say
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

All the Best Deals For Prime Day 2025

Add to Cart, Stat! Big Prime Day Deals All the Top Steals & Discounts Published…

July 8, 2025

‘Politically Repurposed’ Copy of Famous Shakespearean Love Sonnet Discovered Inside a 17th-Century Poetry Collection

Veronese has found is a crucial piece of evidence that shows how Shakespeare's work was…

March 26, 2025

Judge Orders Release of Tufts Student Detained by ICE

A federal judge in Vermont has made a significant ruling ordering the Trump administration to…

May 9, 2025

Scott Jennings Says the Democratic Party Is Going to Get Hit ‘with the Equivalent of a Nuclear Bomb’ Next Week |

The Deterioration of Biden: Political Theatre or Genuine Crisis? Former President Joe Biden’s cognitive decline…

May 10, 2025

Dennis Rodman’s ex-wife sums up her feelings over daughter Trinity’s major Wimbledon outrage

Trinity Rodman, daughter of former NBA star Dennis Rodman, made headlines at Wimbledon for more…

July 9, 2025

You Might Also Like

Study highlights potentially dangerous e-cigarette modifications by youth, adults
Health and Wellness

Study highlights potentially dangerous e-cigarette modifications by youth, adults

July 22, 2025
New CDER director at FDA, how rescissions affect health policy
Health and Wellness

New CDER director at FDA, how rescissions affect health policy

July 22, 2025
Four-day work week benefits workers, employers, study says
Health and Wellness

Four-day work week benefits workers, employers, study says

July 22, 2025
Breakthroughs Changing The Diagnosis And Treatment Of Alzheimer’s
Health and Wellness

Breakthroughs Changing The Diagnosis And Treatment Of Alzheimer’s

July 22, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?